4906.5000 65.50 (1.35%)
NSE Jun 27, 2025 15:31 PM
Volume: 113.9K
 

4906.50
1.35%
Motilal Oswal
After MNC Pharma and pure-play companies like ERIS, ALKEM has minimal exposure to the international business. It has multiple growth drivers over the next 12-18 months, despite a high base in the past 12 months, due to: a) a revival in Non-COVID therapies and better MR productivity (14% net addition over the past two years), b) sustained outperformance in Chronic...
Alkem Laboratories Ltd. is trading below all available SMAs
More from Alkem Laboratories Ltd.
Recommended